Happy to see the Scoping Study scheduled for December. Although the phrasing yesterday of "promptly followed by PFS" is today followed by a H1 2022 date as opposed to Q1 2022.
Hard to interpret the results based on the unknowns in this report. I could've sworn in the AGM presentation last year there was a graph/bar chart broadly explaining the composition of the price E25 would obtain and what the breakeven point was. Can't seem to find it and cbf digging for it.
Happy to see the Scoping Study scheduled for December. Although...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.025(9.80%) |
Mkt cap ! $64.01M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 29.0¢ | 25.5¢ | $143.4K | 521.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 14649 | 1 |
View Market Depth
| Last trade - 16.11pm 25/07/2025 (20 minute delay) ? |
| E25 (ASX) Chart |